Skip to main content
Top
Published in: Virology Journal 1/2022

Open Access 01-12-2022 | SARS-CoV-2 | Case Report

Case report: BA.1 subvariant showing a BA.2-like pattern using a variant-specific PCR assay due to a single point mutation downstream the spike 69/70 deletion

Authors: Carlos Daviña-Nuñez, Sonia Pérez-Castro, Lucía Martínez-Lamas, Jorge Julio Cabrera-Alvargonzález, Sonia Rey-Cao, Raquel Carballo-Fernandez, Montse Godoy-Diz, Leticia López-Bóveda, Victor del Campo-Pérez, Silvia Suárez-Luque, Benito Regueiro-García

Published in: Virology Journal | Issue 1/2022

Login to get access

Abstract

Background:

SARS-CoV-2 variant tracking is key to the genomic surveillance of the COVID-19 pandemic. While next-generation sequencing (NGS) is commonly used for variant determination, it is expensive and time-consuming. Variant-specific PCR (vsPCR) is a faster, cheaper method that detects specific mutations that are considered variant-defining. These tests usually rely on specific amplification when a mutation is present or a specific melting temperature peak after amplification.

Case presentation:

A discrepant result between vsPCR and NGS was found in seventeen SARS-CoV-2 samples from Galicia, Spain. A cluster of BA.1 Omicron SARS-CoV-2 variant showed a BA.2-like melting temperature pattern due to a point mutation (C21772T) downstream the deletion of the spike amino acids 69/70. As the 69/70 deletion is widely used for differentiation between BA.1 and BA.2 by vsPCR, C21772T can cause BA.1 samples to be misinterpreted as BA.2. Over a thousand BA.1 sequences in the EpiCoV database contain this mutation.

Conclusions:

To our knowledge, this is the first case of a point mutation causing a vsPCR algorithm to misclassify BA.1 samples as BA.2. This is an example of how mutations in the probe target area of vsPCR tests based on melting curve analysis can lead to variant misclassification. NGS confirmation of vsPCR results is relevant for the accuracy of the epidemiological surveillance. In order to overcome the possible impact of novel mutations, diagnostic tools must be constantly updated.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ong DSY, Koeleman JGM, Vaessen N, Breijer S, Paltansing S, de Man P. Rapid screening method for the detection of SARS-CoV–2 variants of concern. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2021 Aug;141:104903.CrossRef Ong DSY, Koeleman JGM, Vaessen N, Breijer S, Paltansing S, de Man P. Rapid screening method for the detection of SARS-CoV–2 variants of concern. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2021 Aug;141:104903.CrossRef
2.
go back to reference Molenkamp R, Fanoy E, Derickx L, Groot T de, Jonges M, Leenstra T, et al. Supplementing SARS-CoV–2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021. Eurosurveillance. 2021 Oct 7;26(40):2100921. Molenkamp R, Fanoy E, Derickx L, Groot T de, Jonges M, Leenstra T, et al. Supplementing SARS-CoV–2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021. Eurosurveillance. 2021 Oct 7;26(40):2100921.
3.
go back to reference Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C. Omicron SARS-CoV–2 variant: What we know and what we don’t. Anaesth Crit Care Pain Med. 2022 Feb;41(1):100998.CrossRefPubMed Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C. Omicron SARS-CoV–2 variant: What we know and what we don’t. Anaesth Crit Care Pain Med. 2022 Feb;41(1):100998.CrossRefPubMed
6.
go back to reference covSPECTRUM [Internet]. [cited 2022 May 16]. Available from: https://cov-spectrum.org. covSPECTRUM [Internet]. [cited 2022 May 16]. Available from: https://​cov-spectrum.​org.​
7.
go back to reference Yu G. Using ggtree to Visualize Data on Tree-Like Structures. Curr Protoc Bioinforma. 2020;69(1):e96.CrossRef Yu G. Using ggtree to Visualize Data on Tree-Like Structures. Curr Protoc Bioinforma. 2020;69(1):e96.CrossRef
9.
go back to reference Bodenhofer U, Bonatesta E, Horejš-Kainrath C, Hochreiter S. msa: an R package for multiple sequence alignment. Bioinformatics. 2015 Dec 15;31(24):3997–9. Bodenhofer U, Bonatesta E, Horejš-Kainrath C, Hochreiter S. msa: an R package for multiple sequence alignment. Bioinformatics. 2015 Dec 15;31(24):3997–9.
11.
go back to reference Pereira-Gómez M, Fajardo Á, Echeverría N, López-Tort F, Perbolianachis P, Costábile A, et al. Evaluation of SYBR Green real time PCR for detecting SARS-CoV–2 from clinical samples. J Virol Methods. 2021 Mar 1;289:114035. Pereira-Gómez M, Fajardo Á, Echeverría N, López-Tort F, Perbolianachis P, Costábile A, et al. Evaluation of SYBR Green real time PCR for detecting SARS-CoV–2 from clinical samples. J Virol Methods. 2021 Mar 1;289:114035.
12.
go back to reference Abdel Sater F, Younes M, Nassar H, Nguewa P, Hamze K. A rapid and low-cost protocol for the detection of B. 1.1. 7 lineage of SARS-CoV–2 by using SYBR Green-based RT-qPCR. Mol Biol Rep. 2021;48(11):7243–9.CrossRefPubMedPubMedCentral Abdel Sater F, Younes M, Nassar H, Nguewa P, Hamze K. A rapid and low-cost protocol for the detection of B. 1.1. 7 lineage of SARS-CoV–2 by using SYBR Green-based RT-qPCR. Mol Biol Rep. 2021;48(11):7243–9.CrossRefPubMedPubMedCentral
13.
go back to reference Ziegler K, Steininger P, Ziegler R, Steinmann J, Korn K, Ensser A. SARS-CoV–2 samples may escape detection because of a single point mutation in the N gene. Eurosurveillance. 2020 Oct 1;25(39):2001650. Ziegler K, Steininger P, Ziegler R, Steinmann J, Korn K, Ensser A. SARS-CoV–2 samples may escape detection because of a single point mutation in the N gene. Eurosurveillance. 2020 Oct 1;25(39):2001650.
16.
go back to reference Camp JV, Buchta C, Jovanovic J, Puchhammer-Stöckl E, Benka B, Griesmacher A, et al. RT-PCR based SARS-CoV–2 variant screening assays require careful quality control. J Clin Virol. 2021;141:104905.CrossRefPubMedPubMedCentral Camp JV, Buchta C, Jovanovic J, Puchhammer-Stöckl E, Benka B, Griesmacher A, et al. RT-PCR based SARS-CoV–2 variant screening assays require careful quality control. J Clin Virol. 2021;141:104905.CrossRefPubMedPubMedCentral
17.
go back to reference Sit BHM, Po KHL, Cheung YY, Tsang AKL, Leung PKL, Zheng J, et al. Detection of SARS-CoV–2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays. J Clin Virol Plus. 2022 Aug 1;2(3):100091. Sit BHM, Po KHL, Cheung YY, Tsang AKL, Leung PKL, Zheng J, et al. Detection of SARS-CoV–2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays. J Clin Virol Plus. 2022 Aug 1;2(3):100091.
18.
go back to reference Dächert C, Muenchhoff M, Graf A, Autenrieth H, Bender S, Mairhofer H, et al. Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV–2 variants. Med Microbiol Immunol (Berl). 2022 Feb;211(1)(1):71–7.CrossRef Dächert C, Muenchhoff M, Graf A, Autenrieth H, Bender S, Mairhofer H, et al. Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV–2 variants. Med Microbiol Immunol (Berl). 2022 Feb;211(1)(1):71–7.CrossRef
19.
go back to reference Caduff L, Dreifuss D, Schindler T, Devaux AJ, Ganesanandamoorthy P, Kull A, et al. Inferring transmission fitness advantage of SARS-CoV–2 variants of concern from wastewater samples using digital PCR, Switzerland, December 2020 through March 2021. Eurosurveillance. 2022 Mar 10;27(10):2100806. Caduff L, Dreifuss D, Schindler T, Devaux AJ, Ganesanandamoorthy P, Kull A, et al. Inferring transmission fitness advantage of SARS-CoV–2 variants of concern from wastewater samples using digital PCR, Switzerland, December 2020 through March 2021. Eurosurveillance. 2022 Mar 10;27(10):2100806.
20.
go back to reference Bian L, Gao Q, Gao F, Wang Q, He Q, Wu X, et al. Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev Vaccines. 2021 Oct;3(10):1201–9. 20(.CrossRef Bian L, Gao Q, Gao F, Wang Q, He Q, Wu X, et al. Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev Vaccines. 2021 Oct;3(10):1201–9. 20(.CrossRef
21.
go back to reference Twohig KA, Nyberg T, Zaidi A, Thelwall S, Sinnathamby MA, Aliabadi S, et al. Hospital admission and emergency care attendance risk for SARS-CoV–2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2022 Jan 1;22(1):35–42. Twohig KA, Nyberg T, Zaidi A, Thelwall S, Sinnathamby MA, Aliabadi S, et al. Hospital admission and emergency care attendance risk for SARS-CoV–2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2022 Jan 1;22(1):35–42.
22.
go back to reference Ren SY, Wang WB, Gao RD, Zhou AM. Omicron variant (B.1.1.529) of SARS-CoV–2: Mutation, infectivity, transmission, and vaccine resistance. World J Clin Cases. 2022 Jan 7;10(1):1–11. Ren SY, Wang WB, Gao RD, Zhou AM. Omicron variant (B.1.1.529) of SARS-CoV–2: Mutation, infectivity, transmission, and vaccine resistance. World J Clin Cases. 2022 Jan 7;10(1):1–11.
23.
go back to reference Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, Møller CH, et al. Risk of hospitalisation associated with infection with SARS-CoV–2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis. 2022 Jul 1;22(7):967–76. Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, Møller CH, et al. Risk of hospitalisation associated with infection with SARS-CoV–2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis. 2022 Jul 1;22(7):967–76.
Metadata
Title
Case report: BA.1 subvariant showing a BA.2-like pattern using a variant-specific PCR assay due to a single point mutation downstream the spike 69/70 deletion
Authors
Carlos Daviña-Nuñez
Sonia Pérez-Castro
Lucía Martínez-Lamas
Jorge Julio Cabrera-Alvargonzález
Sonia Rey-Cao
Raquel Carballo-Fernandez
Montse Godoy-Diz
Leticia López-Bóveda
Victor del Campo-Pérez
Silvia Suárez-Luque
Benito Regueiro-García
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
SARS-CoV-2
Published in
Virology Journal / Issue 1/2022
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-022-01883-2

Other articles of this Issue 1/2022

Virology Journal 1/2022 Go to the issue